Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 1/2022

01-01-2022 | Review Article

PGC-1: a key regulator in bone homeostasis

Authors: Haoling Chen, Wenguo Fan, Hongwen He, Fang Huang

Published in: Journal of Bone and Mineral Metabolism | Issue 1/2022

Login to get access

Abstract

Peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) is an inducible co-regulator of nuclear receptors and is involved in a wide variety of biological responses. As the master regulators of mitochondrial biogenesis and function, PGC-1α and PGC-1β have been reported to play key roles in bone metabolism. They can be rapidly induced under conditions of increased metabolic activities, such as osteoblastogenesis and osteoclastogenesis, to fulfill greater energy demand or facilitate other biochemical reactions. PGC-1α and PGC-1β have both overlapping and distinct functions with each other among their target organs. In bone homeostasis, PGC-1α and PGC-1β promote the expression of genes required for mitochondrial biogenesis via coactivator interactions with key transcription factors, respectively regulating osteoblastogenesis and osteoclastogenesis. Here, we review the current understanding of how PGC-1α and PGC-1β affect osteoblastogenesis and osteoclastogenesis, how these two PGC-1 coactivators are regulated in bone homeostasis, and how we can translate these findings into therapeutic potential for bone metabolic diseases.
Literature
2.
go back to reference Liu C, Lin JD (2011) PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin (Shanghai) 43:248–257CrossRef Liu C, Lin JD (2011) PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin (Shanghai) 43:248–257CrossRef
3.
go back to reference Andersson U, Scarpulla RC (2001) Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 21:3738–3749PubMedPubMedCentralCrossRef Andersson U, Scarpulla RC (2001) Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 21:3738–3749PubMedPubMedCentralCrossRef
4.
go back to reference Zheng CX, Sui BD, Qiu XY, Hu CH, Jin Y (2020) Mitochondrial regulation of stem cells in bone homeostasis. Trends Mol Med 26:89–104PubMedCrossRef Zheng CX, Sui BD, Qiu XY, Hu CH, Jin Y (2020) Mitochondrial regulation of stem cells in bone homeostasis. Trends Mol Med 26:89–104PubMedCrossRef
6.
go back to reference Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259–266PubMedCrossRef Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259–266PubMedCrossRef
7.
go back to reference Colaianni G, Lippo L, Sanesi L, Brunetti G, Celi M, Cirulli N, Passeri G, Reseland J, Schipani E, Faienza MF, Tarantino U, Colucci S, Grano M (2018) Deletion of the transcription factor PGC-1alpha in mice negatively regulates bone mass. Calcif Tissue Int 103:638–652PubMedCrossRef Colaianni G, Lippo L, Sanesi L, Brunetti G, Celi M, Cirulli N, Passeri G, Reseland J, Schipani E, Faienza MF, Tarantino U, Colucci S, Grano M (2018) Deletion of the transcription factor PGC-1alpha in mice negatively regulates bone mass. Calcif Tissue Int 103:638–652PubMedCrossRef
8.
go back to reference Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813:1269–1278PubMedCrossRef Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813:1269–1278PubMedCrossRef
9.
go back to reference Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124PubMedCrossRef Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124PubMedCrossRef
10.
go back to reference Yu B, Huo L, Liu Y, Deng P, Szymanski J, Li J, Luo X, Hong C, Lin J, Wang CY (2018) PGC-1alpha controls skeletal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing TAZ. Cell Stem Cell 23:193-209.e195PubMedPubMedCentralCrossRef Yu B, Huo L, Liu Y, Deng P, Szymanski J, Li J, Luo X, Hong C, Lin J, Wang CY (2018) PGC-1alpha controls skeletal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing TAZ. Cell Stem Cell 23:193-209.e195PubMedPubMedCentralCrossRef
11.
go back to reference Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM (2006) Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 3:333–341PubMedCrossRef Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM (2006) Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab 3:333–341PubMedCrossRef
13.
go back to reference Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147PubMedCrossRef Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147PubMedCrossRef
14.
go back to reference Lee AR, Moon DK, Siregar A, Moon SY, Jeon RH, Son YB, Kim BG, Hah YS, Hwang SC, Byun JH, Woo DK (2019) Involvement of mitochondrial biogenesis during the differentiation of human periosteum-derived mesenchymal stem cells into adipocytes, chondrocytes and osteocytes. Arch Pharm Res 42:1052–1062PubMedCrossRef Lee AR, Moon DK, Siregar A, Moon SY, Jeon RH, Son YB, Kim BG, Hah YS, Hwang SC, Byun JH, Woo DK (2019) Involvement of mitochondrial biogenesis during the differentiation of human periosteum-derived mesenchymal stem cells into adipocytes, chondrocytes and osteocytes. Arch Pharm Res 42:1052–1062PubMedCrossRef
15.
go back to reference Hsu YC, Wu YT, Yu TH, Wei YH (2016) Mitochondria in mesenchymal stem cell biology and cell therapy: from cellular differentiation to mitochondrial transfer. Semin Cell Dev Biol 52:119–131PubMedCrossRef Hsu YC, Wu YT, Yu TH, Wei YH (2016) Mitochondria in mesenchymal stem cell biology and cell therapy: from cellular differentiation to mitochondrial transfer. Semin Cell Dev Biol 52:119–131PubMedCrossRef
16.
go back to reference Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH (2008) Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26:960–968PubMedCrossRef Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH (2008) Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26:960–968PubMedCrossRef
17.
go back to reference Handschin C (2009) The biology of PGC-1alpha and its therapeutic potential. Trends Pharmacol Sci 30:322–329PubMedCrossRef Handschin C (2009) The biology of PGC-1alpha and its therapeutic potential. Trends Pharmacol Sci 30:322–329PubMedCrossRef
18.
go back to reference Sanchez-de-Diego C, Artigas N, Pimenta-Lopes C, Valer JA, Torrejon B, Gama-Perez P, Villena JA, Garcia-Roves PM, Rosa JL, Ventura F (2019) Glucose restriction promotes osteocyte specification by activating a PGC-1alpha-dependent transcriptional program. J Physiol 15:79–94 Sanchez-de-Diego C, Artigas N, Pimenta-Lopes C, Valer JA, Torrejon B, Gama-Perez P, Villena JA, Garcia-Roves PM, Rosa JL, Ventura F (2019) Glucose restriction promotes osteocyte specification by activating a PGC-1alpha-dependent transcriptional program. J Physiol 15:79–94
19.
go back to reference Huang PI, Chou YC, Chang YL, Chien Y, Chen KH, Song WS, Peng CH, Chang CH, Lee SD, Lu KH, Chen YJ, Kuo CH, Hsu CC, Lee HC, Yung MC (2011) Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1alpha overexpression. Int J Mol Sci 12:7554–7568PubMedPubMedCentralCrossRef Huang PI, Chou YC, Chang YL, Chien Y, Chen KH, Song WS, Peng CH, Chang CH, Lee SD, Lu KH, Chen YJ, Kuo CH, Hsu CC, Lee HC, Yung MC (2011) Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1alpha overexpression. Int J Mol Sci 12:7554–7568PubMedPubMedCentralCrossRef
20.
go back to reference Park-Min KH (2018) Mechanisms involved in normal and pathological osteoclastogenesis. Cell Mol Life Sci 75:2519–2528PubMedCrossRef Park-Min KH (2018) Mechanisms involved in normal and pathological osteoclastogenesis. Cell Mol Life Sci 75:2519–2528PubMedCrossRef
21.
go back to reference Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K, Albrecht O, Schulz O, Krishnacoumar B, Kronke G, Herrmann M, Mougiakakos D, Strowig T, Schett G, Zaiss MM (2018) Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun 9:55PubMedPubMedCentralCrossRef Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K, Albrecht O, Schulz O, Krishnacoumar B, Kronke G, Herrmann M, Mougiakakos D, Strowig T, Schett G, Zaiss MM (2018) Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun 9:55PubMedPubMedCentralCrossRef
22.
go back to reference Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM et al (2006) Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4:e369PubMedPubMedCentralCrossRef Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM et al (2006) Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4:e369PubMedPubMedCentralCrossRef
23.
go back to reference Ma JD, Jing J, Wang JW, Mo YQ, Li QH, Lin JZ, Chen LF, Shao L, Miossec P, Dai L (2019) Activation of the peroxisome proliferator-activated receptor gamma coactivator 1beta/NFATc1 pathway in circulating osteoclast precursors associated with bone destruction in rheumatoid arthritis. Arthritis Rheumatol 71:1252–1264PubMedPubMedCentralCrossRef Ma JD, Jing J, Wang JW, Mo YQ, Li QH, Lin JZ, Chen LF, Shao L, Miossec P, Dai L (2019) Activation of the peroxisome proliferator-activated receptor gamma coactivator 1beta/NFATc1 pathway in circulating osteoclast precursors associated with bone destruction in rheumatoid arthritis. Arthritis Rheumatol 71:1252–1264PubMedPubMedCentralCrossRef
24.
go back to reference Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361–370PubMedCrossRef Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1:361–370PubMedCrossRef
25.
go back to reference Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM (2002) Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 277:1645–1648PubMedCrossRef Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM (2002) Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 277:1645–1648PubMedCrossRef
26.
go back to reference Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79:208–217PubMedCrossRef Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79:208–217PubMedCrossRef
27.
go back to reference Zaccagnino P, Saltarella M, Maiorano S, Gaballo A, Santoro G, Nico B, Lorusso M, Del Prete A (2012) An active mitochondrial biogenesis occurs during dendritic cell differentiation. Int J Biochem Cell Biol 44:1962–1969PubMedCrossRef Zaccagnino P, Saltarella M, Maiorano S, Gaballo A, Santoro G, Nico B, Lorusso M, Del Prete A (2012) An active mitochondrial biogenesis occurs during dendritic cell differentiation. Int J Biochem Cell Biol 44:1962–1969PubMedCrossRef
28.
go back to reference Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, Mohan S (2007) Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J Biol Chem 282:22052–22061PubMedCrossRef Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ, Mohan S (2007) Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J Biol Chem 282:22052–22061PubMedCrossRef
29.
go back to reference Jiang LL, Zhang FP, He YF, Fan WG, Zheng MM, Kang J, Huang F, He HW (2019) Melatonin regulates mitochondrial function and biogenesis during rat dental papilla cell differentiation. Eur Rev Med Pharmacol Sci 23:5967–5979PubMed Jiang LL, Zhang FP, He YF, Fan WG, Zheng MM, Kang J, Huang F, He HW (2019) Melatonin regulates mitochondrial function and biogenesis during rat dental papilla cell differentiation. Eur Rev Med Pharmacol Sci 23:5967–5979PubMed
30.
go back to reference Shen Y, Wu L, Qin D, Xia Y, Zhou Z, Zhang X (2018) Carbon black suppresses the osteogenesis of mesenchymal stem cells: the role of mitochondria. Part Fibre Toxicol 15:16PubMedPubMedCentralCrossRef Shen Y, Wu L, Qin D, Xia Y, Zhou Z, Zhang X (2018) Carbon black suppresses the osteogenesis of mesenchymal stem cells: the role of mitochondria. Part Fibre Toxicol 15:16PubMedPubMedCentralCrossRef
31.
go back to reference Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O’Rahilly S, Montague C, Vidal-Puig AJ (2003) Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 373:155–165PubMedPubMedCentralCrossRef Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O’Rahilly S, Montague C, Vidal-Puig AJ (2003) Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 373:155–165PubMedPubMedCentralCrossRef
32.
go back to reference Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM (2003) PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem 278:30843–30848PubMedCrossRef Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM (2003) PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem 278:30843–30848PubMedCrossRef
33.
go back to reference Wei W, Wang X, Yang M, Smith LC, Dechow PC, Sonoda J, Evans RM, Wan Y (2010) PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11:503–516PubMedPubMedCentralCrossRef Wei W, Wang X, Yang M, Smith LC, Dechow PC, Sonoda J, Evans RM, Wan Y (2010) PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss. Cell Metab 11:503–516PubMedPubMedCentralCrossRef
34.
go back to reference Park UH, Yoon SK, Park T, Kim EJ, Um SJ (2011) Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor. J Biol Chem 286:1354–1363PubMedCrossRef Park UH, Yoon SK, Park T, Kim EJ, Um SJ (2011) Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor. J Biol Chem 286:1354–1363PubMedCrossRef
35.
go back to reference Izawa T, Rohatgi N, Fukunaga T, Wang QT, Silva MJ, Gardner MJ, McDaniel ML, Abumrad NA, Semenkovich CF, Teitelbaum SL, Zou W (2015) ASXL2 regulates glucose, lipid, and skeletal homeostasis. Cell Rep 11:1625–1637PubMedPubMedCentralCrossRef Izawa T, Rohatgi N, Fukunaga T, Wang QT, Silva MJ, Gardner MJ, McDaniel ML, Abumrad NA, Semenkovich CF, Teitelbaum SL, Zou W (2015) ASXL2 regulates glucose, lipid, and skeletal homeostasis. Cell Rep 11:1625–1637PubMedPubMedCentralCrossRef
36.
go back to reference Bonnelye E, Kung V, Laplace C, Galson DL, Aubin JE (2002) Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. Endocrinology 143:3658–3670PubMedCrossRef Bonnelye E, Kung V, Laplace C, Galson DL, Aubin JE (2002) Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. Endocrinology 143:3658–3670PubMedCrossRef
37.
go back to reference Wang H, Wang J (2013) Estrogen-related receptor alpha interacts cooperatively with peroxisome proliferator-activated receptor-gamma coactivator-1alpha to regulate osteocalcin gene expression. Cell Biol Int 37:1259–1265PubMed Wang H, Wang J (2013) Estrogen-related receptor alpha interacts cooperatively with peroxisome proliferator-activated receptor-gamma coactivator-1alpha to regulate osteocalcin gene expression. Cell Biol Int 37:1259–1265PubMed
38.
go back to reference Kammerer M, Gutzwiller S, Stauffer D, Delhon I, Seltenmeyer Y, Fournier B (2013) Estrogen Receptor alpha (ERalpha) and Estrogen Related Receptor alpha (ERRalpha) are both transcriptional regulators of the Runx2-I isoform. Mol Cell Endocrinol 369:150–160PubMedCrossRef Kammerer M, Gutzwiller S, Stauffer D, Delhon I, Seltenmeyer Y, Fournier B (2013) Estrogen Receptor alpha (ERalpha) and Estrogen Related Receptor alpha (ERRalpha) are both transcriptional regulators of the Runx2-I isoform. Mol Cell Endocrinol 369:150–160PubMedCrossRef
39.
go back to reference Bonnelye E, Saltel F, Chabadel A, Zirngibl RA, Aubin JE, Jurdic P (2010) Involvement of the orphan nuclear estrogen receptor-related receptor alpha in osteoclast adhesion and transmigration. J Mol Endocrinol 45:365–377PubMedPubMedCentralCrossRef Bonnelye E, Saltel F, Chabadel A, Zirngibl RA, Aubin JE, Jurdic P (2010) Involvement of the orphan nuclear estrogen receptor-related receptor alpha in osteoclast adhesion and transmigration. J Mol Endocrinol 45:365–377PubMedPubMedCentralCrossRef
40.
go back to reference Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, Takahashi N, Kawada T, Miyoshi M, Ezaki O, Kakizuka A (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA 100:12378–12383PubMedPubMedCentralCrossRef Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, Takahashi N, Kawada T, Miyoshi M, Ezaki O, Kakizuka A (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA 100:12378–12383PubMedPubMedCentralCrossRef
41.
go back to reference Epstein PM (2012) Bone and the cAMP signaling pathway: emerging therapeutics. In: Bronner F, Farach-Carson M, Roach H (eds) Bone-metabolic functions and modulators. Topics in Bone Biology, vol 7. Springer, London, pp 271–287 Epstein PM (2012) Bone and the cAMP signaling pathway: emerging therapeutics. In: Bronner F, Farach-Carson M, Roach H (eds) Bone-metabolic functions and modulators. Topics in Bone Biology, vol 7. Springer, London, pp 271–287
42.
go back to reference Nervina JM, Magyar CE, Pirih FQ, Tetradis S (2006) PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone 39:1018–1025PubMedCrossRef Nervina JM, Magyar CE, Pirih FQ, Tetradis S (2006) PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone 39:1018–1025PubMedCrossRef
43.
go back to reference Blagodatski A, Klimenko A, Jia L, Katanaev VL (2020) Small molecule Wnt pathway modulators from natural sources: history, state of the art and perspectives. Cells 9:589PubMedCentralCrossRef Blagodatski A, Klimenko A, Jia L, Katanaev VL (2020) Small molecule Wnt pathway modulators from natural sources: history, state of the art and perspectives. Cells 9:589PubMedCentralCrossRef
44.
go back to reference Maeda K, Kobayashi Y, Koide M, Uehara S, Okamoto M, Ishihara A, Kayama T, Saito M, Marumo K (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci 20:5525PubMedCentralCrossRef Maeda K, Kobayashi Y, Koide M, Uehara S, Okamoto M, Ishihara A, Kayama T, Saito M, Marumo K (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci 20:5525PubMedCentralCrossRef
45.
go back to reference An JH, Yang JY, Ahn BY, Cho SW, Jung JY, Cho HY, Cho YM, Kim SW, Park KS, Kim SY, Lee HK, Shin CS (2010) Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells. Bone 47:140–150PubMedCrossRef An JH, Yang JY, Ahn BY, Cho SW, Jung JY, Cho HY, Cho YM, Kim SW, Park KS, Kim SY, Lee HK, Shin CS (2010) Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells. Bone 47:140–150PubMedCrossRef
46.
go back to reference Min W, Fang P, Huang G, Shi M, Zhang Z (2018) The decline of whole-body glucose metabolism in ovariectomized rats. Nat Commun 113:106–112 Min W, Fang P, Huang G, Shi M, Zhang Z (2018) The decline of whole-body glucose metabolism in ovariectomized rats. Nat Commun 113:106–112
47.
go back to reference Zhou JJ, Ma JD, Mo YQ, Zheng DH, Chen LF, Wei XN, Dai L (2014) Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation. Arthritis Res Ther 16:472PubMedPubMedCentralCrossRef Zhou JJ, Ma JD, Mo YQ, Zheng DH, Chen LF, Wei XN, Dai L (2014) Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation. Arthritis Res Ther 16:472PubMedPubMedCentralCrossRef
48.
go back to reference Shapiro G, Fishleder J, Stepensky P, Simanovsky N, Goldman V, Lamdan R (2020) Skeletal changes following hematopoietic stem cell transplantation in osteopetrosis. J Bone Miner Res 35:1645–1651PubMedCrossRef Shapiro G, Fishleder J, Stepensky P, Simanovsky N, Goldman V, Lamdan R (2020) Skeletal changes following hematopoietic stem cell transplantation in osteopetrosis. J Bone Miner Res 35:1645–1651PubMedCrossRef
49.
go back to reference Han X, Nonaka K, Kato H, Yamaza H, Sato H, Kifune T, Hirofuji Y, Masuda K (2019) Osteoblastic differentiation improved by bezafibrate-induced mitochondrial biogenesis in deciduous tooth-derived pulp stem cells from a child with Leigh syndrome. Biochem Biophys Rep 17:32–37PubMed Han X, Nonaka K, Kato H, Yamaza H, Sato H, Kifune T, Hirofuji Y, Masuda K (2019) Osteoblastic differentiation improved by bezafibrate-induced mitochondrial biogenesis in deciduous tooth-derived pulp stem cells from a child with Leigh syndrome. Biochem Biophys Rep 17:32–37PubMed
50.
go back to reference Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP, Sebedio JL, Pujos-Guillot E, Falempin M, Simon C, Coxam V, Andrianjafiniony T, Gauquelin-Koch G, Picquet F, Blanc S (2011) Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. Faseb J 25:3646–3660PubMedCrossRef Momken I, Stevens L, Bergouignan A, Desplanches D, Rudwill F, Chery I, Zahariev A, Zahn S, Stein TP, Sebedio JL, Pujos-Guillot E, Falempin M, Simon C, Coxam V, Andrianjafiniony T, Gauquelin-Koch G, Picquet F, Blanc S (2011) Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. Faseb J 25:3646–3660PubMedCrossRef
51.
go back to reference Pal S, Maurya SK, Chattopadhyay S, Pal China S, Porwal K, Kulkarni C, Sanyal S, Sinha RA, Chattopadhyay N (2019) The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts. Biochem Pharmacol 164:34–44PubMedPubMedCentralCrossRef Pal S, Maurya SK, Chattopadhyay S, Pal China S, Porwal K, Kulkarni C, Sanyal S, Sinha RA, Chattopadhyay N (2019) The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts. Biochem Pharmacol 164:34–44PubMedPubMedCentralCrossRef
52.
go back to reference Deng T, Sieglaff DH, Zhang A, Lyon CJ, Ayers SD, Cvoro A, Gupte AA, Xia X, Baxter JD, Webb P, Hsueh WA (2011) A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial function. J Biol Chem 286:30723–30731PubMedPubMedCentralCrossRef Deng T, Sieglaff DH, Zhang A, Lyon CJ, Ayers SD, Cvoro A, Gupte AA, Xia X, Baxter JD, Webb P, Hsueh WA (2011) A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial function. J Biol Chem 286:30723–30731PubMedPubMedCentralCrossRef
Metadata
Title
PGC-1: a key regulator in bone homeostasis
Authors
Haoling Chen
Wenguo Fan
Hongwen He
Fang Huang
Publication date
01-01-2022
Publisher
Springer Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2022
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-021-01263-w

Other articles of this Issue 1/2022

Journal of Bone and Mineral Metabolism 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.